Amortization of premiums and accretion of discounts related to investments, net
4,345
9,182
Amortization of debt issuance costs
1,779
3,434
Interest credited to policyholders
25,143
47,809
Change in allowance for losses on trade receivables
54
-1,423
Operating lease right-of-use asset amortization
2,260
4,553
Net gain on sale of real and personal property
-26,300
-60,432
Net losses on disposal of real estate
2,696
2,914
Net (gains) losses on sales of fixed maturity securities
673
-3,029
Net gains on equity securities
5,049
126
Deferred income taxes
27,290
72,387
Reinsurance recoverables and trade receivables
-3,041
-56,525
Inventories and parts
-1,116
13,004
Prepaid expenses
36,767
33,534
Capitalization of deferred policy acquisition costs
-2,939
-2,612
Other assets
-10,324
13,028
Related party assets
9,844
3,143
Increase (decrease) in accounts payable and accrued liabilities
-97,274
80,415
Policy benefits and losses, claims and loss expenses payable
26,957
36,096
Other policyholders' funds and liabilities
-139
-1,615
Deferred income
-4,068
2,873
Related party liabilities
-4,172
1,542
Net cash provided by operating activities
240,599
1,149,996
Increase decrease escrow deposits
148
581
Property, plant and equipment
688,167
1,914,502
Fixed maturity investments
106,487
159,726
Equity securities
73
3,458
Investments, other
60,721
84,265
Property, plant and equipment
185,486
386,058
Fixed maturity investments
124,417
186,042
Equity securities
8,041
6,704
Investments, other
22,078
85,240
Net cash used by investing activities
-515,278
-1,497,326
Borrowings from credit facilities
808,808
951,543
Principal repayments on credit facilities
476,394
425,838
Payment of debt issuance costs
4,794
5,808
Finance lease payments
8,208
24,693
Securitization deposits
121
224
Series n non-voting common stock dividends paid
8,824
17,647
Investment contract deposits
65,494
181,834
Investment contract withdrawals
155,915
222,462
Net cash provided by financing activities
220,288
437,153
Effects of exchange rate on cash
3,828
4,169
Cash, cash equivalent, restricted cash, and restricted cash equivalent, period increase (decrease), including exchange rate effect and discontinued operation, total
-50,563
93,992
Cash and cash equivalents at beginning of period
1,082,820
988,828
Cash and cash equivalents at end of period
1,032,257
1,082,820
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.